Aradigm
PrivateLast Round
Series A
Dec 9, 2025
Est. Valuation
$25M
Total Funding Raised
$30M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Aradigm is a healthcare technology company that provides a benefits platform for cell and gene therapies designed to provide sustainable access to life-saving medicines.
Sector
Healthcare & Life Sciences
Verticals
InsurTech, Biotechnology, Compliance & Risk
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aradigm Comparables
Compare Aradigm with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Real Endpoints | 33% | |
| Audaire Health | 32% | |
| Quantile Health | 30% |
Aradigm Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
Aradigm Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series A, Seed |
| Frist Cressey Ventures | Series A |
| Morgan Health | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 102% MoM, reaching 4.4K.
- Jul 29, 2026
Grew 25% QoQ, from 16 to 20 employees.
Aradigm Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Aradigm's valuation, stock price, and market status.
Is Aradigm a public or private company?
Aradigm is a private company.
What is the current stock price of Aradigm?
Aradigm is a private company, so its shares have no public market price. Caplight tracks Aradigm's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aradigm worth (valuation)?
Aradigm's valuation is estimated at $25.0M based on funding round data.
Can I buy Aradigm stock?
Aradigm shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aradigm's last funding round?
Aradigm's most recent funding round was Series A on December 9, 2025.
Who are the main investors in Aradigm?
Key investors in Aradigm include Andreessen Horowitz, Frist Cressey Ventures.
Will Aradigm IPO soon?
No public IPO plans have been announced for Aradigm.
How can I track Aradigm secondary market activity?
Caplight tracks bids, offers, and trades in Aradigm's shares on secondary markets.